-
公开(公告)号:CA2560454A1
公开(公告)日:2005-10-13
申请号:CA2560454
申请日:2005-03-30
Applicant: VERTEX PHARMA
Inventor: BETHIEL RANDY , FRAYSSE DAMIEN , SALITURO FRANCESCO , FARMER LUC , COURT JOHN , MORTIMORE MICHAEL , LAUFFER DAVID , BOYALL DEAN , ARONOV ALEX , EVERITT SIMON , PIERARD FRANCOISE , COME JON , CHARRIER JEAN-DAMIEN , GREEN JEREMY , ROBINSON DANIEL , BINCH HAYLEY , HARRINGTON EDMUND , WANG JIAN , PIERCE ALBERT , PINDER JOANNE , WANG TIANSHENG
IPC: C07D471/04 , C07D519/00
Abstract: The present invention relates to compounds of formula (I), which are inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
-
公开(公告)号:PL357177A1
公开(公告)日:2004-07-26
申请号:PL35717701
申请日:2001-02-09
Applicant: VERTEX PHARMA
Inventor: TOMLINSON RONALD , LAUFFER DAVID , MULLICAN MICHAEL
IPC: A61K31/40 , A61K31/4025 , A61K31/427 , A61K31/4523 , A61K31/454 , A61K31/4545 , A61K31/496 , A61K31/4995 , A61K31/506 , A61K38/22 , A61K38/27 , A61P19/04 , A61P21/00 , A61P21/04 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/14 , A61P25/16 , A61P25/28 , A61P29/00 , C07D20060101 , C07D205/04 , C07D207/16 , C07D209/52 , C07D211/26 , C07D211/60 , C07D211/62 , C07D211/78 , C07D277/06 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D417/06 , C07D417/12 , C07D487/08
Abstract: The present invention relates to piperazine and piperidine derivatives, which are especially useful for treating or preventing neuronal damage, particularly damage associated with neurological diseases. These compounds are also useful for stimulating nerve growth. The invention also provides compositions comprising the compounds of the present invention and methods of utilizing those compositions for treating or preventing neuronal damage or for stimulating nerve growth.
-
公开(公告)号:EE200200442A
公开(公告)日:2003-12-15
申请号:EEP200200442
申请日:2001-02-09
Applicant: VERTEX PHARMA
Inventor: TOMLINSON RONALD , LAUFFER DAVID , MULLICAN MICHAEL
IPC: A61K31/40 , A61K31/4025 , A61K31/427 , A61K31/4523 , A61K31/454 , A61K31/4545 , A61K31/496 , A61K31/4995 , A61K31/506 , A61K38/22 , A61K38/27 , A61P19/04 , A61P21/00 , A61P21/04 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/14 , A61P25/16 , A61P25/28 , A61P29/00 , C07D20060101 , C07D205/04 , C07D207/16 , C07D209/52 , C07D211/26 , C07D211/60 , C07D211/62 , C07D211/78 , C07D277/06 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D417/06 , C07D417/12 , C07D487/08
Abstract: The present invention relates to piperazine and piperidine derivatives, which are especially useful for treating or preventing neuronal damage, particularly damage associated with neurological diseases. These compounds are also useful for stimulating nerve growth. The invention also provides compositions comprising the compounds of the present invention and methods of utilizing those compositions for treating or preventing neuronal damage or for stimulating nerve growth.
-
公开(公告)号:CO5261503A1
公开(公告)日:2003-03-31
申请号:CO01009891
申请日:2001-02-09
Applicant: VERTEX PHARMA
Inventor: TOMLINSON RONALD CHARLES , LAUFFER DAVID , MULLICAN MICHAEL
IPC: A61K31/40 , A61K31/4025 , A61K31/427 , A61K31/445 , A61K31/4523 , A61K31/454 , A61K31/4545 , A61K31/496 , A61K31/4995 , A61K31/506 , A61K38/22 , A61K38/27 , A61P19/04 , A61P21/00 , A61P21/04 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/14 , A61P25/16 , A61P25/28 , A61P29/00 , C07D20060101 , C07D205/04 , C07D207/16 , C07D209/52 , C07D211/26 , C07D211/60 , C07D211/62 , C07D211/78 , C07D277/06 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D417/06 , C07D417/12 , C07D487/08
Abstract: Un compuesto de la fórmula: en donde:cada Q es un sistema de anillo monocíclico, bicíclico o tricíclico, en donde en dicho sistema de anillo:cada anillo es independientemente insaturado de manera parcial o completamente saturado;cada anillo comprende 3 a 7 átomos de anillo independientemente seleccionado de C, N, O o S;no más de cuatro átomos del anillo en Q son seleccionados de N, O o S;cualquier S es opcionalmente reemplazado con S (O) o S(O)2;al menos un anillo comprende un átomo de anillo N que es sustituido con R1;f. De uno a cinco átomos de hidrógeno en Q son opcional e independientemente reemplazados con halo-OH, =O, =N-OR1, alquilo recto o ramificado (C1-C6), alquilo Ar- sustituido-(C1-C6)-recto o ramificado, alquenilo o alquinilo recto o ramificado (C2-C6), alquenilo o alquinilo Ar-sustituido-g. (C2C6)-recto o ramificado, alquilo O-C1-C6)-recto o ramificado, O-[alquilo (C1-C6)-recto o ramificado]-Ar, alquenilo o alquinilo O-(C2-C6)-recto o ramificado, O-[alquenilo o alquinilo (C2-C6)-recto o ramificado]-Ar, o O-Ar; y - 2 -h. Q no es un indol o una porción piroglutámica, en dondeCada R1 es independientemente seleccionado de alquilo (C1-C6)-recto o ramificado, alquilo Ar-sustituido-(C1-C6)-recto o ramificado, alquilo cicloalquilo (C1-C6)-recto o ramificado, o alquenilo o alquinilo (C2-C6)-recto o ramificado, o alquenilo alquinilo Ar-sustituido-(C2-C6)-recto o ramificado; en dondeUno a dos grupos CH2 de dichas cadenas de alquilo, alquenilo, o alquinilo, en R1 son opcional e independientemente reemplazadas con O, S, S(O), S(O)2, C(O) o N(R2), en donde cuando R1 está unido al nitrógeno, el grupo CH2 del R1 unido directamente a dicho nitrógeno no puede ser reemplazado con C(O);Ar se selecciona de fenilo, 1-naftilo, 2-naftilo, indenilo, azulenilo, 2-furilo, 3-furilo, 2-tienilo, 3-tienilo, 2-piridilo, 3-piridilo, 4-piridilo, pirrolilo, oxazolilo, tiazolilo, imidazolilo, piraxolilo, pirazolinilo, piraolidinilo, isoxazolilo, isotiazolilo, 1,2,3-oxadiazolilo, 1,2,3-triazolilo, 1,3,4-tiadiazolilo, 1,2,4-triazolilo, 1,2,4-oxadiazolilo, 1,2,4-tiadiazolilo, 1,2,3-tiadiazolilo, benoxazolilo, piridazinilo, 2-pirimidinilo, 4- pirimidinilo, 5- pirimidinilo, pirazinilo, 1,3,5-triazinilo, 1,3,5-tritianilo, indolisinilo, indolilo, isoindolilo, 3H-indolilo, indolinilo, benzo[b]furanilo, benzo[b]tiofenilo, 1H-indazolilo, benzimidiazolilo, benztiazolilo, purinilo, 4H-quinolisinilo, quinolinilo, 1,2,3,4-tetrahidroisoquinolinilo, isoquinolinilo, 1,2,3,4-tetrahidroquinolinilo, cinolinilo, eftalasinilo, quinazolinilo, quinoxalinilo, 1,8-naftiridinilo, o cualquier otro sistema de anillo monocíclico o bicíclico químicamente factible, en donde cada anillo consiste de 5 a 7 átomos de anillo en donde cada anillo comprende 0 a 3 héteroátomos independientemente seleccionados de N, O, o S, en dondeCada Ar es opcionalmente e independientemente sustituido con uno a tres sustituyentes seleccionados de halo, hidroxi, nitro, =O, -SO3H, trifluorometilo, trifluorometoxi, alquilo (C1-C6)-recto o ramificado, alquenilo (C1-C6)-recto o ramificado, O-[alquilo (C1-C6)-recto o ramificado], O-[alquenilo (C1-C6)-recto o ramificado], O-benzilo, O-fenilo, 1,2-metilenedioxi, -N(R3)(R4), carboxilo, N-(alquilo (C1-C6)-recto o ramificado o alquenilo (C2-C6)-recto o ramificado) carboxamidas, N,N-di-(alquilo C1-C6-recto o ramificado o alquenilo C2-C6-recto o ramificado) carboxamidas, N-(alquilo C1-C6-recto o ramificado o alquenilo C2-C6-recto o ramificado) sulfonamidas, o N,N-di-(alquilo C1-C6-recto o ramificado o alquenilo C2-C6-recto o ramificado) sulfonamidas;Cada uno de los R3 y R4 son independientemente seleccionados de alquilo (C1-C6)-recto o ramificado, alquenilo o alquinilo (C2-C6)-recto o ramificado, hidrógeno, fenilo o benzilo, o en donde R3 y R4 son tomados juntos con el átomo de nitrógeno al cual ellos están unidos para formar un anillo héterocíclico de 5 a 7 miembros;Cada R2 es independientemente seleccionado de hidrógeno, alquilo (C1-C6)-recto o ramificado, o alquenilo o alquinilo (C2-C6)-recto o ramificado;X se selecciona de C(R2)2, N(R2), N, O, S, S(O), o S(O)2;Y se selecciona de un enlace, -O-, alquilo (C1-C6)-recto o ramificado, o alquenilo o alquinilo (C2-C6)-recto o ramificado; en donde Y está unido al anillo descrito vía un enlace simple o un enlace doble; y en donde uno a dos de los grupos CH2 de dicho alquilo, alquenilo o alquinilo está opcional e independientemente reemplazado con O, As, S(O), S(O)2, C(O) o N(R2);Z es -C(O)- o -CH2-P es 0, 1 o 2;Cada uno de A y B es independientemente seleccionado de hidrógeno o Ar; o uno de A o B está ausente; yEn donde dos átomos del anillo de carbono en la estructura del anillo descrita están opcionalmente unidos uno al otro por vía de un alquilo C1-C4 recto o un alquenilo C2-C4 recto para crear una porción bicíclica.
-
公开(公告)号:BR0108175A
公开(公告)日:2003-01-28
申请号:BR0108175
申请日:2001-02-09
Applicant: VERTEX PHARMA
Inventor: TOMLINSON RONALD , LAUFFER DAVID , MULLICAN MICHAEL
IPC: A61K31/40 , A61K31/4025 , A61K31/427 , A61K31/4523 , A61K31/454 , A61K31/4545 , A61K31/496 , A61K31/4995 , A61K31/506 , A61K38/22 , A61K38/27 , A61P19/04 , A61P21/00 , A61P21/04 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/14 , A61P25/16 , A61P25/28 , A61P29/00 , C07D20060101 , C07D205/04 , C07D207/16 , C07D209/52 , C07D211/26 , C07D211/60 , C07D211/62 , C07D211/78 , C07D277/06 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D417/06 , C07D417/12 , C07D487/08
Abstract: The present invention relates to piperazine and piperidine derivatives, which are especially useful for treating or preventing neuronal damage, particularly damage associated with neurological diseases. These compounds are also useful for stimulating nerve growth. The invention also provides compositions comprising the compounds of the present invention and methods of utilizing those compositions for treating or preventing neuronal damage or for stimulating nerve growth.
-
26.
公开(公告)号:CA2450074A1
公开(公告)日:2002-12-27
申请号:CA2450074
申请日:2002-06-13
Applicant: VERTEX PHARMA
Inventor: BOTFIELD MARTYN , TOMLINSON RONALD , OTTOW ECKARD , LAUFFER DAVID
IPC: C07D295/18 , A61K31/445 , A61K31/495 , A61K45/00 , A61P3/10 , A61P9/10 , A61P19/00 , A61P19/02 , A61P21/00 , A61P21/04 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/28 , A61P25/30 , A61P43/00 , C07B61/00 , C07D211/16 , C07D295/185 , C07D241/04 , A61K31/395 , A61K31/496
Abstract: The present invention relates to acyclic piperazine and piperidine derivatives, which are especially useful for treating or preventing neuronal damage, particularly damage associated with neurological diseases. These compounds are also useful for stimulating nerve growth. The invention also provides compositions comprising the compounds of the present invention and methods of utilizing those compositions for treating or preventing neuronal damage or for stimulating nerve growth.
-
27.
公开(公告)号:CZ20022720A3
公开(公告)日:2002-11-13
申请号:CZ20022720
申请日:2001-02-09
Applicant: VERTEX PHARMA
Inventor: TOMLINSON RONALD , LAUFFER DAVID , MULLICAN MICHAEL
IPC: A61K31/40 , A61K31/4025 , A61K31/427 , A61K31/4523 , A61K31/454 , A61K31/4545 , A61K31/496 , A61K31/4995 , A61K31/506 , A61K38/22 , A61K38/27 , A61P19/04 , A61P21/00 , A61P21/04 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/14 , A61P25/16 , A61P25/28 , A61P29/00 , C07D20060101 , C07D205/04 , C07D207/16 , C07D209/52 , C07D211/26 , C07D211/60 , C07D211/62 , C07D211/78 , C07D277/06 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D417/06 , C07D417/12 , C07D487/08
Abstract: The present invention relates to piperazine and piperidine derivatives, which are especially useful for treating or preventing neuronal damage, particularly damage associated with neurological diseases. These compounds are also useful for stimulating nerve growth. The invention also provides compositions comprising the compounds of the present invention and methods of utilizing those compositions for treating or preventing neuronal damage or for stimulating nerve growth.
-
公开(公告)号:PE20020451A1
公开(公告)日:2002-06-06
申请号:PE2001000931
申请日:2001-09-14
Applicant: VERTEX PHARMA
Inventor: DAVIES ROBERT , BEBBINGTON DAVID , KNEGTEL RONALD , WANNAMAKER MARION , LI PAN , FORSTER CORNELIA J , LAUFFER DAVID , PIERCE ALBERT , KAY DAVID
IPC: C07D403/12 , A61K31/415 , A61K31/4155 , A61K31/437 , A61K31/4427 , A61K31/4709 , A61K31/4725 , A61K31/501 , A61K31/5025 , A61K31/506 , A61K31/517 , A61K31/519 , A61K31/52 , A61K31/53 , A61K31/5377 , A61K31/541 , A61K31/55 , A61K45/00 , A61P1/16 , A61P3/08 , A61P3/10 , A61P3/14 , A61P5/00 , A61P9/00 , A61P9/10 , A61P11/06 , A61P17/06 , A61P19/00 , A61P19/02 , A61P19/10 , A61P25/18 , A61P25/28 , A61P29/00 , A61P31/12 , A61P35/00 , A61P35/02 , A61P37/02 , A61P37/06 , A61P37/08 , A61P43/00 , C07D239/26 , C07D239/36 , C07D239/70 , C07D239/88 , C07D401/12 , C07D401/14 , C07D403/14 , C07D405/14 , C07D407/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D473/16 , C07D475/10 , C07D487/04 , C07D491/04 , C07D491/044 , C07D491/048 , C07D491/052 , C07D491/107 , C07D491/113 , C07D491/20 , C07D493/04 , C07D495/04 , C07D498/04 , C07D513/04 , C07D521/00
Abstract: SE REFIERE A COMPUESTOS DE PIRAZOL DE FORMULA I DONDE EL ANILO C ES FENILO, PIRIDINILO, PIRIMIDINILO, PIRIDAZINILO, PIRAZINILO, 1,2,4-TRIAZINILO SUSTITUIDO EN LA POSICION ORTO POR HALO, CN, NO2, T-V-R6, FENILO, HETEROARILO, HETEROCICLO, UN GRUPO ALIFATICO C1-C6; EN LA POSICION DIFERENTE DE ORTO ES SUSTITUIDO POR R5; R1 Y R2 SON R, R-W-R6, ANILLO DE 5-8 MIEMBROS SUSTITUIDO CON HALO, OXO, CN, NO2R7, VR6; Rx Y Ry SON T-R3, ANILLO FUSIONADO SUSTITUIDO CON T-R3, OXO, R4; T ES ENLACE, ALQUILIDENO, C1-C4; R3 ES R, HALO, OR, COR, N(R4)2, CON(R7)2, ENTRE OTROS; R ES H, ARILO C6-C10, HETEROARILO C5-C10, HETEROCICLO 5-10 MIEMBROS; R4 ES R7, CON(R7)2, SO2R7; R7 ES H, GRUPO ALIFATICO, DOS R7 FORMAN HETEROARILO, HETEROCICLO; R5 ES R, HALO, OR, NR4COR, COCOR, ENTRE OTROS; V ES O, S, SO, SO2, NR6SO2, SO2NR6, CONR6, ENTRE OTROS; R6 ES H, GRUPO ALIFATICO C1-C4, DOS R6 FORMAN HETEROARILO, HETEROCICLO; W ES C(R6)2O, C(R6)2S, CO2, CONR6. TAMBIEN SE REFIERE A COMPUESTOS DE FORMULA A, B, ENTRE OTROS; R10 ES F, Br, HALOALQUILO C1-C6, NITRO, 1-PIRROLO; R1 ES Cl, F, CF3, CN, NO2; LOS COMPUESTOS SON INHIBIDORES DE LA ACTIVIDAD DE CINASAS GLICOGENO SINTASA GSK-3; SERINA TREONINA AURORA-2, AUMENTAN LA SINTESIS DE GLICOGENO, DISMINUYEN NIVEL SANGUINEO DE GLUCOSA, INHIBEN LA PRODUCCION DE PROTEINA TAU HIPERFOSFORILADA, INHIBEN LA FOSFORILACION DE ß-CATEINA Y PUEDEN SER UTILES PARA EL TRATAMIENTO DE DIABETES, ALZHEIMER, ESQUIZOFRENIA, CANCER
-
公开(公告)号:AU6076000A
公开(公告)日:2001-02-19
申请号:AU6076000
申请日:2000-07-06
Applicant: VERTEX PHARMA
Inventor: MULLICAN MICHAEL , LAUFFER DAVID
IPC: A61K31/4409 , A61K31/444 , A61K38/00 , A61K38/22 , A61K38/27 , A61K45/00 , A61P3/10 , A61P9/00 , A61P11/00 , A61P19/00 , A61P21/00 , A61P21/04 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/28 , A61P29/00 , A61P39/02 , A61P43/00 , C07D213/40 , A61K31/4427
Abstract: The present invention relates to cyclic amine derivatives for treating or preventing neuronal damage associated with neurological diseases. The invention also provides compositions comprising the compounds of the present invention and methods of utilizing those compositions for treating or preventing neuronal damage.
-
公开(公告)号:CA2379993A1
公开(公告)日:2001-02-08
申请号:CA2379993
申请日:2000-07-27
Applicant: VERTEX PHARMA
Inventor: MULLICAN MICHAEL , LAUFFER DAVID , TUNG ROGER
IPC: C07D333/22 , A61K31/137 , A61K31/165 , A61K31/27 , A61K31/381 , A61K31/40 , A61K31/4025 , A61K31/41 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4439 , A61K31/444 , A61K45/00 , A61P3/10 , A61P17/04 , A61P19/00 , A61P21/00 , A61P21/04 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/14 , A61P25/16 , A61P25/28 , A61P25/30 , A61P29/00 , A61P41/00 , A61P43/00 , C07C211/27 , C07C211/28 , C07C211/29 , C07C215/28 , C07C225/16 , C07C233/11 , C07C233/13 , C07C233/18 , C07C233/31 , C07C233/65 , C07C233/66 , C07C233/69 , C07C233/76 , C07C235/78 , C07C271/12 , C07C271/14 , C07C271/16 , C07C271/18 , C07C327/44 , C07D207/06 , C07D207/16 , C07D213/38 , C07D213/40 , C07D213/50 , C07D213/53 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D409/06 , C07D213/06 , C07D211/06 , A61K38/18 , C07D211/32 , A61K31/44 , A61K31/445
Abstract: The present invention relates to acyclic and cyclic amine derivatives for treating or preventing neuronal damage associated with neurological diseases . The invention also provides compositions comprising the compounds of the present invention and methods of utilizing those compositions for treating o r preventing neuronal damage.
-
-
-
-
-
-
-
-
-